What Are Antibiotics? History, Production, and the Future

Antibiotics are bioactive compounds that inhibit or kill harmful microorganisms. Derived from living systems—most often microorganisms—they are manufactured on an industrial scale via controlled fermentation. Though their therapeutic principles were not elucidated until the 20th century, the Chinese first harnessed antibiotic‐like agents over 2,500 years ago. Today, more than 10,000 distinct antibiotic substances have been catalogued, and the global industry is a multibillion‑dollar enterprise that continues to grow.

Background

Antibiotics are formulated in a variety of dosage forms, each with specific manufacturing demands. Topical infections of skin, eye, or ear are treated with ointments or creams, while systemic infections require oral tablets, capsules, or parenteral solutions. In systemic use, the drug is absorbed into the bloodstream, distributing throughout the body.

Chemical diversity among antibiotics dictates their spectrum and mode of action. Some compromise bacterial cell‑wall integrity, causing lysis; others damage membranes, leading to leakage of cellular contents. Additional mechanisms target essential bacterial processes: protein synthesis (e.g., tetracycline, erythromycin), nucleic‑acid biosynthesis (e.g., rifampin), or general metabolic pathways (e.g., sulfonamides, trimethoprim).

The journey from laboratory discovery to market launch is lengthy and expensive. It begins with high‑throughput screening of thousands of microorganisms for antibacterial activity. Promising strains undergo large‑scale cultivation to isolate the active compound, followed by rigorous pre‑clinical testing in animals and humans to confirm safety and efficacy. Once successful, the drug must receive FDA approval—a process that can span a decade.

Large‑scale production hinges on fermentation. High‑yield and easy downstream isolation are essential for economic viability. Extensive process development precedes commercial scale‑up.

History

While modern science only recently unraveled antibiotic mechanisms, the practical use of antibiotic‑like substances dates back centuries. The earliest recorded application was by Chinese artisans around 2,500 years ago, who applied moldy soybean curd to wounds with remarkable results. Evidence indicates that the Sudanese‑Nubian civilization employed a tetracycline‑type antibiotic around 350 A.D., and medieval Europeans used crude plant extracts and cheese curds to fight infection. The underlying principles, however, remained unknown until the 20th century.

Louis Pasteur pioneered the idea that microorganisms could suppress disease-causing bacteria. In 1877, he demonstrated that a saprophytic bacterium could inhibit anthrax bacilli. Alexander Fleming’s 1928 discovery of the Penicillium mold’s antibacterial activity launched the modern era of antibiotics. Subsequent refinements by Howard Florey and colleagues in the 1940s produced high‑yield penicillin strains, enabling large‑scale manufacturing.

The term “antibiotic” entered scientific lexicon in 1939 during investigations of soil bacteria Streptomyces. Selman Waxman isolated streptomycin in 1944, and later discoveries included actinomycin, streptothricin, neomycin, bacitracin, polymyxin, viomycin, chloramphenicol, and tetracyclines. Since the 1970s, most new antibiotics have been synthetic derivatives of natural products.

Raw Materials

The fermentation broth—the primary raw material—is an aqueous solution packed with nutrients that sustain the growth of antibiotic‑producing microbes. Typical components include carbon sources such as molasses or soybean meal (rich in lactose and glucose), nitrogen sources like ammonium salts, and trace elements (phosphorus, sulfur, magnesium, zinc, iron, copper) delivered as water‑soluble salts. Anti‑foaming agents—lard oil, octadecanol, or silicones—are added to prevent foaming during fermentation.

The Manufacturing Process

Although many antibiotics exist naturally, their natural yields are insufficient for commercial production. Therefore, a meticulous fermentation strategy is employed. The process requires sterile conditions to avoid contamination that could ruin the batch.

Starting the Culture

• 1. Isolate the desired antibiotic‑producing strain and expand its population. A starter culture is prepared by transferring the organism to an agar plate, then to shake flasks containing growth media, creating a suspension that is transferred to seed tanks.
• 2. Seed tanks—steel vessels designed for optimal microbial growth—are filled with a mixture of warm water, carbohydrates (lactose or glucose), additional carbon sources (acetic acid, alcohols, hydrocarbons), nitrogen sources (ammonium salts), vitamins, amino acids, and minor nutrients. Mixers keep the medium homogeneous, and sterilized air is pumped in. After 24–28 hours, the inoculum is transferred to the primary fermentation tanks.

Fermentation

• 3. The primary fermentation tank holds ~30,000 gallons of the same growth medium. It maintains temperatures of 73–81 °F (23–27 °C), continuous agitation, and a steady flow of sterilized air. Anti‑foaming agents are periodically added, and pH is tightly controlled with acids or bases.

Isolation and Purification

• 4. After 3–5 days, maximum antibiotic production is achieved. The broth is processed using methods tailored to the compound’s solubility: ion‑exchange chromatography for water‑soluble antibiotics, solvent extraction (e.g., butyl acetate, methyl isobutyl ketone) for oil‑soluble antibiotics like penicillin. The result is a purified powder that can be formulated into final products.

Refining

• 5. Final product forms vary: intravenous solutions, gel capsules, powders for ointments. Each requires specific refining steps—dissolution, encapsulation, or mixing—before packaging.
• 6. Finished goods are boxed, palletized, and shipped to distributors, hospitals, and pharmacies. The entire fermentation–purification–packaging sequence takes roughly 5–8 days.

Quality Control

Rigorous quality control safeguards product integrity. All media and equipment undergo steam sterilization. During fermentation, microbial cultures are monitored by chromatography and other analytical techniques. Physical and chemical attributes—pH, melting point, moisture content—are regularly tested. In the U.S., the FDA mandates batch‑level testing for efficacy and purity, granting market clearance only after certification.

The Future

Drug development is capital‑intensive, and antibiotic research has slowed over the last decade. Yet the emergence of resistant bacteria has reignited global urgency. Addressing this threat will require renewed investment in novel antibiotics and optimization of existing therapies. The scientific community and industry are now poised to tackle this challenge over the coming years.